# Female‐biased astrocytic priming shapes early locus coeruleus vulnerability in an Aβ oligomer milieu

**Authors:** Srishti Kushwaha, Rupsa Roy Choudhury, Priyanka Bhat, S. Senthil Kumaran, Smitha Karunakaran

PMC · DOI: 10.1002/alz.71168 · Alzheimer's & Dementia · 2026-02-06

## TL;DR

Female mice show early astrocyte changes in a brain region linked to Alzheimer's disease, which may explain sex differences in disease vulnerability.

## Contribution

This study reveals sex-specific astrocytic priming in the locus coeruleus during early Alzheimer's pathology in mice.

## Key findings

- Females exhibit higher brainstem Aβ42 oligomers and astrocyte-specific MRS signatures.
- Environmental enrichment reverses astrocytic and noradrenergic changes in female APP/PS1 mice.
- Female astrocytes show elevated lactate and oxidative phosphorylation transcripts without morphological changes.

## Abstract

The locus coeruleus (LC) is an early site of Alzheimer's disease (AD) pathology, yet the role of brainstem astrocytes in early, sex‐dependent vulnerability remains unclear.

In 2‐ to 3‐month‐old APP/PS1 mice, we combined in vivo proton magnetic resonance spectroscopy (MRS) of the brainstem with region‐resolved molecular analyses, including quantitative real‐time polymerase chain reaction, amyloid beta 42 (Aβ42) oligomers enzyme‐linked immunosorbent assay, lactate assay, immunohistochemistry, immunoblotting, astrocyte isolation, and 3D structural assessment. Environmental enrichment (EE) served as a non‐pharmacologic intervention.

Females exhibited higher brainstem Aβ42 oligomers and an astrocyte‐weighted MRS profile. Pontine glial fibrillary acidic protein (GFAP), complement component 3, and nuclear factor kappa‐light‐chain‐enhancer of activated B cells were selectively upregulated without pan‐reactive astrocytic and microglial markers. LC‐restricted GFAP elevation occurred without changes in astrocyte counts or morphology, indicating a “primed” state. Females also showed higher lactate levels, increased monocarboxylate transporter 2 expression, and elevations in selected oxidative phosphorylation‐associated transcripts, and reduced astrocytic alpha 2A‐adrenergic receptor expression. EE normalized noradrenergic and pontine astrocytic changes.

Female‐biased, LC‐centric astrocytic priming emerges early in this amyloid‐driven model and is modifiable.

Early astrocytic priming in locus coeruleus (LC) of APP/PS1 mice is stronger in females.Non‐reactive astrocytes show glial fibrillary acidic protein, complement component 3, nuclear factor kappa‐light‐chain‐enhancer of activated B cells upregulation with intact LC neurons.Females show higher glutamine, myo‐inositol, glutathione, and taurine levels.Noradrenergic tuning adapts in males via NET/α2A receptors but is impaired in females.Environmental enrichment restores LC astrocytic state, metabolic profile, and noradrenergic regulation.

Early astrocytic priming in locus coeruleus (LC) of APP/PS1 mice is stronger in females.

Non‐reactive astrocytes show glial fibrillary acidic protein, complement component 3, nuclear factor kappa‐light‐chain‐enhancer of activated B cells upregulation with intact LC neurons.

Females show higher glutamine, myo‐inositol, glutathione, and taurine levels.

Noradrenergic tuning adapts in males via NET/α2A receptors but is impaired in females.

Environmental enrichment restores LC astrocytic state, metabolic profile, and noradrenergic regulation.

## Linked entities

- **Genes:** GFAP (glial fibrillary acidic protein) [NCBI Gene 2670], ELK3 (ETS transcription factor ELK3) [NCBI Gene 2004]
- **Chemicals:** Aβ42 (PubChem CID 8820), lactate (PubChem CID 61503), glutamine (PubChem CID 738), myo-inositol (PubChem CID 892), glutathione (PubChem CID 124886), taurine (PubChem CID 1123)
- **Diseases:** Alzheimer's disease (MONDO:0004975)

## Full-text entities

- **Genes:** Slc1a3 (solute carrier family 1 (glial high affinity glutamate transporter), member 3) [NCBI Gene 20512] {aka B430115D02Rik, Eaat1, GLAST, GLAST-1, GLU-T, GluT-1}, S100a10 (S100 calcium binding protein A10 (calpactin)) [NCBI Gene 20194] {aka 42C, CAL12, CLP11, Cal1l, p10, p11}, C3ar1 (complement component 3a receptor 1) [NCBI Gene 12267] {aka AZ3B, C3AR, HNFAG09}, Il1b (interleukin 1 beta) [NCBI Gene 16176] {aka IL-1beta, Il-1b}, Bace1 (beta-site APP cleaving enzyme 1) [NCBI Gene 23821] {aka ASP2, Bace}, App (amyloid beta precursor protein) [NCBI Gene 11820] {aka Abeta, Abpp, Adap, Ag, Cvap, E030013M08Rik}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Slc6a2 (solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2) [NCBI Gene 20538] {aka NE-T, NET, Slc6a5}, C3 (complement component 3) [NCBI Gene 12266] {aka ASP, HSE-MSF, Plp}, MAPT (microtubule associated protein tau) [NCBI Gene 4137] {aka DDPAC, FTD1, FTDP-17, MAPTL, MSTD, MTBT1}, Dbh (dopamine beta hydroxylase) [NCBI Gene 13166], Atp5f1a (ATP synthase F1 subunit alpha) [NCBI Gene 11946] {aka Atp5a1, Atpm, D18Ertd206e, Mom2}, Cx3cr1 (C-X3-C motif chemokine receptor 1) [NCBI Gene 13051] {aka mCX3CR1}, Nfkb2 (nuclear factor of kappa light polypeptide gene enhancer in B cells 2, p49/p100) [NCBI Gene 18034] {aka NF-kappaB2, lyt, p49, p49/p100, p50B, p52}, Sdhb (succinate dehydrogenase complex, subunit B, iron sulfur (Ip)) [NCBI Gene 67680] {aka 0710008N11Rik}, Slc17a5 (solute carrier family 17 (anion/sugar transporter), member 5) [NCBI Gene 235504] {aka 4631416G20Rik, 4732491M05, AST, ISSD, NSD, SD}, Cd68 (CD68 antigen) [NCBI Gene 12514] {aka Lamp4, Scard1, gp110}, Uqcrc1 (ubiquinol-cytochrome c reductase core protein 1) [NCBI Gene 22273] {aka 1110032G10Rik}, Vim (vimentin) [NCBI Gene 22352], Apoe (apolipoprotein E) [NCBI Gene 11816] {aka Apo-E}, Fcr (Fc receptor) [NCBI Gene 109615], Cybb (cytochrome b-245, beta polypeptide) [NCBI Gene 13058] {aka CGD91-phox, Cgd, Cyd, Nox2, gp91-1, gp91phox}, C1qa (complement component 1, q subcomponent, alpha polypeptide) [NCBI Gene 12259] {aka Adic, C1q}, Sox9 (SRY (sex determining region Y)-box 9) [NCBI Gene 20682] {aka 2010306G03Rik, mKIAA4243, mSox9}, Psen1 (presenilin 1) [NCBI Gene 19164] {aka Ad3h, PS-1, PS1, S182}, COX2 (cytochrome c oxidase subunit II) [NCBI Gene 17709], Gfap (glial fibrillary acidic protein) [NCBI Gene 14580], Serpina3n (serine (or cysteine) peptidase inhibitor, clade A, member 3N) [NCBI Gene 20716] {aka Spi2-2, Spi2.2, Spi2/eb.4}, Mylip (myosin regulatory light chain interacting protein) [NCBI Gene 218203] {aka 9430057C20Rik, Mir}, Nfkb1 (nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105) [NCBI Gene 18033] {aka NF-KB1, NF-kappaB, NF-kappaB1, p105, p50, p50/p105}, Nos2 (nitric oxide synthase 2, inducible) [NCBI Gene 18126] {aka MAC-NOS, NOS-II, Nos-2, Nos2a, i-NOS, iNOS}, Ldlr (low density lipoprotein receptor) [NCBI Gene 16835] {aka Hlb301}, Th (tyrosine hydroxylase) [NCBI Gene 21823], APP (amyloid beta precursor protein) [NCBI Gene 351] {aka AAA, ABETA, ABPP, AD1, APPI, CTFgamma}, Adra2a (adrenergic receptor, alpha 2a) [NCBI Gene 11551] {aka Adra-2, Adra-2a, alpha(2A)AR, alpha2-C10, alpha2A, alpha2A-AR}, Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, CHI3L1 (chitinase 3 like 1) [NCBI Gene 1116] {aka ASRT7, CGP-39, GP-39, GP39, HC-gp39, HCGP-3P}, Ndufs8 (NADH:ubiquinone oxidoreductase core subunit S8) [NCBI Gene 225887] {aka CI-23kD, TYKY}, Bdnf (brain derived neurotrophic factor) [NCBI Gene 12064], Slc2a1 (solute carrier family 2 (facilitated glucose transporter), member 1) [NCBI Gene 20525] {aka GT1, Glut-1, Glut1, M100200, Rgsc200}, Cox5b (cytochrome c oxidase subunit 5B) [NCBI Gene 12859], Adora2a (adenosine A2a receptor) [NCBI Gene 11540] {aka A2AAR, A2aR, AA2AR, ARA2A}, Iba1 (induction of brown adipocytes 1) [NCBI Gene 114737], GFAP (glial fibrillary acidic protein) [NCBI Gene 2670] {aka ALXDRD}, Tmem97 (transmembrane protein 97) [NCBI Gene 69071] {aka 1810014L12Rik, D11Bhm182e}, Slc16a7 (solute carrier family 16 (monocarboxylic acid transporters), member 7) [NCBI Gene 20503] {aka 4921534N07Rik, 9030411M13Rik, D630004K10Rik, Mct2}
- **Diseases:** inflammatory (MESH:D007249), astrocytosis (MESH:D005911), suffering (MESH:D010146), dislocation (MESH:D004204), sleep disturbances (MESH:D012893), cognitive decline (MESH:D003072), RESEARCH (MESH:D014947), depression (MESH:D003866), AD (MESH:D000544), LC (OMIM:601308), amyloid (MESH:C000718787), atrophy (MESH:D001284), LC degeneration (MESH:D009410), dementia (MESH:D003704), neurotoxic (MESH:D020258), neuropsychiatric symptoms (MESH:D001523), neurodegeneration (MESH:D019636), NET (MESH:C535600), neuroinflammation (MESH:D000090862), neuropsychiatric burden (MESH:C000631768)
- **Chemicals:** norepinephrine (MESH:D009638), oil (MESH:D009821), lecanemab (MESH:C000612089), creatine (MESH:D003401), water (MESH:D014867), aducanumab (MESH:C000600266), KCl (MESH:D011189), Forane (MESH:D007530), NaCl (MESH:D012965), PB (MESH:D007854), DTT (MESH:D004229), polyacrylamide (MESH:C016679), Taurine (MESH:D013654), glycerol (MESH:D005990), polyvinylidene fluoride (MESH:C024865), Tris-glycine (MESH:C035647), reactive oxygen species (MESH:D017382), sucrose (MESH:D013395), Tween-20 (MESH:D011136), glycogen (MESH:D006003), sodium azide (MESH:D019810), beta-glycerophosphate (MESH:C031463), Triton X-100 (MESH:D017830), PFA (MESH:C003043), CaCl2 (MESH:D002122), N-acetylaspartate (MESH:C000179), Cr (MESH:D002857), sodium citrate (MESH:D000077559), L-Lactate (MESH:D019344), Alexa Fluor  647 (MESH:C569686), Biotin (MESH:D001710), N-acetylaspartyl glutamate (MESH:C027172), Gln (MESH:D005973), guanidine hydrochloride (MESH:D019791), C3 (-), perchloric acid (MESH:C576518), MgSO4 (MESH:D008278), methanol (MESH:D000432), fluorodeoxyglucose (MESH:D019788), DAPI (MESH:C007293), potassium hydroxide (MESH:C029943), glucose (MESH:D005947), sodium fluoride (MESH:D012969), phosphocholine (MESH:D010767), agarose (MESH:D012685), bromophenol blue (MESH:D001978), Glu (MESH:D018698), Alexa Fluor  488 (MESH:C000711379), GSH (MESH:D005978), lipid (MESH:D008055), glycerophosphocholine (MESH:D005997), SDS (MESH:D012967), Myo-inositol (MESH:D007294), nitrogen (MESH:D009584)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090], Rattus norvegicus (brown rat, species) [taxon 10116], Ovis aries (domestic sheep, species) [taxon 9940]
- **Cell lines:** -G — Rattus norvegicus (Rat), Adenocarcinoma of the rat prostate, Cancer cell line (CVCL_3572)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12877963/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12877963/full.md

## References

75 references — full list in the complete paper: https://tomesphere.com/paper/PMC12877963/full.md

---
Source: https://tomesphere.com/paper/PMC12877963